Efficacy and safety of TACE combined with anlotinib compared with TACE alone among patients with intermediate or advanced hepatocellular carcinoma (HCC): A randomized, controlled, phase II clinical study.

被引：0
|
作者：
Zeng, Hui
Shao, Guoliang
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med, Dept Intervent Radiol,Canc Hosp, Hangzhou, Peoples R China
[2] Zhejing Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of anlotinib combined with TACE among patients with intermediate and advanced-stage hepatocellular carcinoma (HCC)
    Zheng, Lin
    Li, Hailiang
    Guo, Chenyang
    Hu, Hongtao
    Li, Fangkun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial
    Zhang, Dinghu
    Zhang, Zhewei
    Luo, Jun
    Zheng, Jiaping
    Mao, Xiaochun
    Tsilimigras, Diamantis I.
    Chun, Ho Jong
    Zeng, Hui
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1627 - 1635
  • [3] Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial
    Lu, Wei
    Jin, Xin-Li
    Yang, Chao
    Du, Peng
    Jiang, Fu-Qiang
    Ma, Jun-Peng
    Yang, Jian
    Xie, Peng
    Zhang, Zhe
    CANCER BIOLOGY & THERAPY, 2017, 18 (06) : 433 - 438
  • [4] Efficacy and safety of transarterial chemoembolization (TACE) plus apatinib as compared with TACE alone for recurrent hepatocellular carcinoma: A prospective randomized controlled trial
    Gu, H.
    Li, J.
    You, N.
    Wu, K.
    Wang, Z.
    Wang, L.
    Zhu, Y.
    Liu, Q.
    Peng, X.
    Zheng, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S219 - S220
  • [5] Investigation of the Difference of Efficacy and Safety of TACE Combined with Sintilimab and Bevacizumab versus TACE Combined with Donafenib in Patients with Intermediate or Advanced Hepatocellular Carcinoma
    Sun, Yanjun
    Wang, Xing
    Ling, Changchun
    Yu, Yong
    Jia, Pengfei
    Lu, Xiaohua
    Zhao, Hui
    Gu, Zhuxin
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S412 - S412
  • [6] The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study
    Yang, Zeran
    Chen, Guang
    Cui, Ye
    Xiao, Guowen
    Su, Tianhao
    Yu, Jianan
    Zhang, Zhiyuan
    Han, Yanjing
    Yang, Kailan
    Jin, Long
    CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 321 - 327
  • [7] A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).
    Chen, Cong
    Fu, Shouzhong
    Zhao, Suming
    Yuan, Hongxin
    Dai, Feng
    Gu, Weiwei
    Gu, Zhuxin
    Shi, Rongfeng
    Yang, Xiaohu
    Lu, Xiaohua
    Jia, Pengfei
    Si, Luyi
    Zhao, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study
    Qu, Shuping
    Zhang, Xiaobing
    Wu, Yutian
    Meng, Yan
    Pan, Hongyu
    Fang, Qiang
    Hu, Lei
    Zhang, Jin
    Wang, Ruoyu
    Wei, Lixin
    Wu, Dong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.
    Zhang, Bin
    Jin, Renan
    Xu, Junjie
    Chen, Ming Yu
    Chen, Jiang
    Zhu, Hepan
    Cao, Jiasheng
    Song, Chao
    Yang, Zaibo
    Zhang, Yewei
    Liang, Xiao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 505 - 505
  • [10] Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma
    Zhu, Yuxia
    Feng, Bo
    Mei, Lin
    Sun, Ruiqing
    Guo, Changcun
    Zhu, Jiangyi
    JOURNAL OF BUON, 2019, 24 (02): : 608 - 614
12345